Filing Flows › Autolus Therapeutics (AUTL) › License revenue revenue
Autolus Therapeutics (AUTL) License revenue revenue by quarter
Autolus Therapeutics' License revenue revenue was $17K in Q2 2026 (second quarter 2026), -98% from Q4 2025. Over the last 3 quarters it ranged from $17K (Q2 2026) to $1.0M (Q4 2025).
| Quarter | License revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $17K | -98% | — |
| Q4 2025 | $1.0M | +900% | — |
| Q3 2025 | $100K | — | — |
Q2 2026 at a glance
Autolus Therapeutics, Q2 2026: revenue $45.7M (+118% year over year), operating margin -95.9%, net loss $39.1M, operating cash flow −$25.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Autolus Therapeutics' License revenue revenue?
Autolus Therapeutics' License revenue revenue was $17K in Q2 2026 (second quarter 2026), -98% from Q4 2025.
How has Autolus Therapeutics' License revenue revenue changed?
Over the last 3 quarters it ranged from $17K (Q2 2026) to $1.0M (Q4 2025).